Oarsman Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.52M |
| 2 |
WFT
Weatherford International plc
WFT
|
+$1.46M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$1.39M |
| 4 |
Verizon
VZ
|
+$1.18M |
| 5 |
Western Digital
WDC
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$1.01M |
| 2 |
Kohl's
KSS
|
+$756K |
| 3 |
Regal Rexnord
RRX
|
+$583K |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$425K |
| 5 |
MCN
Madison Covered Call & Equity Strategy Fund
MCN
|
+$420K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.36% |
| 2 | Financials | 11.88% |
| 3 | Technology | 11.71% |
| 4 | Healthcare | 10.53% |
| 5 | Industrials | 9.24% |
Similar funds
Oarsman Capital's Q3 2018 Portfolio in Review
As of Q3 2018, Oarsman Capital held 188 positions worth $248M, up 13% from $220M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Oarsman Capital deployed $17.9M of net new capital in Q3 2018, opening 9 new positions and adding to 69 existing holdings. Its largest new stake was State Street SPDR Portfolio Developed World ex-US ETF: 45,414 shares worth $1.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Cisco, an estimated $1.01M trimmed.
- Oarsman Capital's largest Q3 2018 buy was State Street SPDR Portfolio Developed World ex-US ETF: 45,414 shares worth $1.4M.
- Oarsman Capital added most to CVS Health in Q3 2018, an estimated $1.52M increase.
- Oarsman Capital's biggest Q3 2018 reduction was Cisco, cutting an estimated $1.01M.
- Oarsman Capital fully exited Madison Covered Call & Equity Strategy Fund in Q3 2018, selling an estimated $420K.
- Oarsman Capital's ten largest holdings make up 23% of its $248M portfolio in Q3 2018.
- Oarsman Capital opened 9 new positions and closed 4 in Q3 2018.
- Oarsman Capital's portfolio value rose 13% quarter-over-quarter to $248M.
Based on Oarsman Capital's 13F filing for Q3 2018, filed 7 Nov 2018.